En

September 21-23, 2020Verona, Italy

The key role of G protein-coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to announce that Evotec, Italy will support the eighth meeting in this series on GPCR drug discovery, which will combine cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.

Deadline for abstract submission for oral communication is January 13, 2020.

Deadline for abstract submission for poster presentation is July 22, 2020.

Bursary application deadline is August 7, 2020.

For more information please contact: maggi@maggichurchouseevents.co.uk

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

September 20-24, 2020Barcelona, Spain

EuroQSAR Symposia are taking place since 1973 and constitute major scientific events in the field of computational drug design, with further applications in agricultural and environmental sciences.

The program will include the following sessions:

  • QSAR without Borders
  • Artificial Intelligence in Drug Design
  • Molecular Dynamics and Kinetics
  • Chemical Space Annotation and Expansion
  • Modelling Drug Safety
  • Challenges in GPCR Drug Design
  • Modelling Drug Transport Mechanisms
  • Predicting Off-Target Pharmacology
  • Network Medicine
  • New Modes of Target Interaction
  • New Trends in Quantum Mechanics
  • Future Challenges Ahead

The 23rd EuroQSAR Symposium, entitled “Integrative Data-Intensive Approaches to Drug Design”, is organised on behalf of QCMS and is chaired by Jordi Mestres (IMIM Hospital del Mar Medical Research Institute).

Deadline for early bird registration and abstract submission for Oral Communications: June 11, 2020

Deadline for abstract submission for Poster Presentation: Auguste 4, 2020

For more information contact: secretariat@ldorganisation.com

October 26-27, 2020Eindhoven, The Netherlands

The Conference topics will include:

  • G-protein coupled receptors
  • Protein-protein interactions
  • Activity-based protein profiling
  • Carbohydrates/glycans
  • Cellular chemistry
  • Bioorthogonal and bioconjugation chemistry
  • Fragment-based drug design
  • Photopharmacology
Organised by:
  • Division Medicinal Chemistry & Chemical Biology, Royal Netherlands Chemical Society (KNCV-MCCB) (The Netherlands)

November 5-7, 2020Athens, Greece

18th Hellenic Symposium on Medicinal Chemistry (HSMC-18) is organized by the Hellenic Society of Medicinal Chemistry (HSMC).

It continues the tradition of biannual meetings established since 35 years in Greece as a forum for the discussion of recent advances in medicinal chemistry. The topics include drug design and lead identification and optimization, protein-protein interactions and protein degradation, ADME/Tox properties, advances in Synthetic Medicinal Chemistry, Natural Products, Pharmacology as well as the impact of artificial intelligence in the integration of data-intensive practices to Drug Discovery. 

For more information please contact: s.si@zita-congress.gr

Organised by:
  • Hellenic Society of Medicinal Chemistry (Greece)

April 2021London, United Kingdom

Cell surface transporters play a key role in human health and disease, both through their impact on drug disposition and as therapeutic targets in their own right. This third meeting in the series will feature talks on transporter structural biology, the impact of transporters on ADME and biodistribution, transporters as therapeutic targets and other aspects of transporters relevant to drug discovery and development. 

For more information please contact: conferences@soci.org

Organised by:

SCI's Fine Chemicals Group, RSC’s Biological and Medicinal Chemistry Sector (BMCS) and the Drug Metabolism Discussion Group (DMDG)


May 4-5, 2021Liverpool, United Kingdom

Members from across the DMPK research community are encouraged to join colleagues from across academic, industrial, and third-sector institutions and contribute to the ongoing discussion, evolution and application of DMPK in various scenarios.

The event programme will incorporate sessions themed around the following key topics:
- DMPK and Drug Discovery
- DMPK and Drug Safety
- Analytical and Computational Advances in DMPK

In addition, the programme also includes a keynote talk, ‘flash’ presentations from early career researchers, and opportunities for open debate and discussion.

For more information please contact: maggi@maggichurchouseevents.co.uk

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)